The ranking of TOP10 antidepressants has changed!

Recently, Shanghai Shangyao Zhongxi Pharmaceutical's duloxetine hydrochloride enteric-coated tablets was approved for supplementary application, and it was the first company to have reviewed the product; Hainan Herui Pharmaceuticals used generic 4 types of venlafaxine hydrochloride to be produced.

The ranking of TOP10 antidepressants has changed! Two "Leaders" with over 1 billion products

Sales of terminal antidepressant drugs in public medical institutions in China in recent years

Source: The terminal competition pattern of China's public medical institutions

According to data from Mi Nei.

From the perspective of the sales structure of manufacturers, Pfizer, Eli Lilly, and Lingbei still rank among the top three foreign pharmaceutical companies, with a combined market share of more than 35%.

TOP10 Terminal Antidepressant Drug Products in China's Public Medical Institutions in 2020

Source: The terminal competition pattern of China's public medical institutions

Among the TOP20 products, 16 products have sales of more than 100 million yuan.

Sales of terminal duloxetine hydrochloride enteric-coated capsules in Chinese public medical institutions in recent years

Source: The terminal competition pattern of China's public medical institutions

Duloxetine is a selective serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor developed by Eli Lilly and is mainly used to treat depression.

Sales of terminal agomelatine tablets in Chinese public medical institutions in recent years

Source: The terminal competition pattern of China's public medical institutions

The original manufacturer of agomelatine is Servier.

It is worth mentioning that in the four batches of centralized procurement carried out by the country, a total of 6 antidepressants have been included.

15 antidepressants have been reviewed, and only 1 company has reviewed 7 products

Antidepressant over-evaluation status

Source: One-key search on Mynet, MED2.

Currently, 15 antidepressant products have been reviewed, involving companies such as Shantouwei Pharmaceutical, Sichuan Kelun Pharmaceutical, Qilu Pharmaceutical (Hainan), and Zhejiang Huahai Pharmaceutical.

Among the reviewed products, only one company has reviewed them, including Beijing Fuyuan Pharmaceutical's Venlafaxine Hydrochloride Sustained Release Capsules, Shanghai Shangyao Zhongxi Pharmaceutical's Duloxetine Hydrochloride Enteric-coated Tablets, and Hunan Dongting Pharmaceutical Co.

11 antidepressants are under review! Zhengda Tianqing, Hausen, Beite.

Source: Meinenet MED2.

At present, a total of 11 generic antidepressant drugs have been submitted for marketing applications and are under review and approval.

Source: Mi Nei.